Certara

1 Abonnés

Certara is a global biosimulation technology-enabled drug development company. Its customers include hundreds of biopharmaceutical companies around the globe, together with several regulatory agencies. Certara’s solutions, which span the discovery, preclinical and clinical stages of drug development, enable data-driven decisions, leading to more precisely designed trials with a reduced risk of failure and improved subject safety. For more information, visit www.certara.com.

drug development pharmaceutical industry veterinary health fda personalized medicine population modeling smoking public health e-cigarettes pediatrics drug discovery 3d qsar comfa

Tout plus

Activité
À propos

Tout plus

Certara

Présentations

Richard Cramer 2014 euro QSAR presentation

Trevor johnson aaps 2014

E-Cigarettes: Promise, Peril, and Probabilistic Population Prediction

Reference scaled average bioequivalence analysis

Use of modelling and simulation to assess and manage individualized risk of drug drug interaction

Martinez use of in silico models to support canine drug development

Documents

IQ consortium survey pkpd modeling in pharma

A milestone in_scientific_publishing_print_infographic(1)